{'fraction_non_alphanumeric': 0.03682170542635659, 'fraction_numerical': 0.01937984496124031, 'mean_word_length': 6.138248847926267, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Effects of Kangshenkeli on high sensitive C-reactive protein and fibrinogen of predialysis patients with chronic renal failure

Objective To observe the effects of Kangshenkeli on serum high sensitive C-reactive protein and plasmic fibrinogen of predialysis patients with chronic renal failure(CRF).Methods A total of 96 patients with chronic renal failure,who were treated in our hospital during Jan 2007 to Oct 2010 without dialysis,were included in the present study and randomly divided into two groups.The control group(32 cases) were treated based on routine therapy for CRF,and the experimental group(64 cases) were treated with Kangshenkeli 12 g a time,3 times per day in addition to routine therapy for CRF.Serum high sensitive C-reactive protein(hs-CRP),plasmic fibrinogen(Fbg),fasting plasma glucose(FPG),hemoglobin(Hb),total cholesterol(TC) and triacylglycerol(TG) before and after treatment were measured.Results After 3 months of treatment,compared with before treatment,serum hs-CRP and plasmic Fbg level were decreased in experimental group(P0.05).There were still significant differences of these two targets in experimental group as compared with control group after treatment(P0.05).Serum level of TC was decreased in experimental group after treatment(P0.05).However,no significant difference of serum TC level was found between experimental group and control group after treatment(P0.05).Conclusion Kangshenkeli may decrease micro-inflammatory states and hypercoagulable states,improve dyslipidemia in predialysis CRF patients.